Literature DB >> 2505524

Gd-DTPA enhancement of posterior epidural scar: an experimental model.

J S Ross1, S Blaser, T J Masaryk, S E Emory, M Bolesta, J Carter, M Aikawa, M T Modic.   

Abstract

Because of the tremendous clinical and physiological importance of anterior epidural scar, an easily produced and reproducible model to assess potential pathways for lessening its formation is a necessity. We speculated whether posterior epidural scar (produced by the less complex surgery of laminectomy alone) could be considered equivalent to anterior scar from an imaging standpoint; that is, enhancement following Gd-DTPA irrespective of scar age. Posterior epidural scar in dogs showed the highest degree of enhancement 1 month after surgery, with a rapid decline thereafter out to 4 months postsurgery to a level equivalent to that of paraspinal muscle. Gd-153-DTPA time/activity curves paralleled the Gd-DTPA findings. Light microscopy showed granulation tissue after 1 month, and mature scar with large amounts of collagen 4 months after surgery. Electron microscopy showed tight capillary endothelial junctions. An appropriate model for epidural scar, which has imaging characteristics similar to human anterior scar, necessitates an extensive lumbar laminectomy with anterior epidural dissection. A simple laminectomy, while easily performed, does not provide a physiologically correct time course of enhancement.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2505524      PMCID: PMC8335293     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  2 in total

Review 1.  Imaging of lumbar degenerative disk disease: history and current state.

Authors:  Todd M Emch; Michael T Modic
Journal:  Skeletal Radiol       Date:  2011-08-17       Impact factor: 2.199

2.  Time-dependent scar enhancement in magnetic resonance imaging of the postoperative lumbar spine.

Authors:  M F Glickstein; S K Sussman
Journal:  Skeletal Radiol       Date:  1991       Impact factor: 2.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.